Akt2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
AKT2 (v-akt murine thymoma viral oncogene homolog 2)
AKT2 (also known as Protein Kinase B beta, PKBβ) is a serine/threonine kinase that is a central node in the PI3K/AKT signaling pathway[1]. AKT2 plays critical roles in cell survival, metabolism, and neuronal function. Dysregulation of AKT2 is implicated in metabolic disorders and neurodegenerative diseases[2].
| Attribute | Value |
|---|---|
| Gene Symbol | AKT2 |
| Full Name | AKT Serine/Threonine Kinase 2 |
| Chromosomal Location | 19q13.2 |
| NCBI Gene ID | 207 |
| OMIM | 164731 |
| Ensembl ID | ENSG00000105221 |
| UniProt | P31751 |
AKT2 is one of three AKT isoforms (AKT1, AKT2, AKT3) with overlapping but distinct functions:
AKT2 is expressed in most tissues with highest expression in:
| Approach | Status | Description |
|---|---|---|
| AKT inhibitors | Research | Cancer therapy, may be relevant for neurodegeneration |
| AKT activators | Research | Potential for neuroprotection |
| Insulin sensitizers | Approved | May indirectly enhance AKT signaling |
AKT exists in three isoforms (AKT1, AKT2, AKT3) with distinct but overlapping functions. AKT2 is the predominant isoform in insulin-sensitive tissues and plays a specialized role in metabolic regulation. All isoforms share a conserved structure with an N-terminal pleckstrin homology (PH) domain, a central kinase domain, and a C-terminal regulatory region.
| Isoform | Tissue Distribution | Primary Functions |
|---|---|---|
| AKT1 | Ubiquitous | Cell growth, survival, angiogenesis |
| AKT2 | Muscle, fat, liver | Insulin signaling, glucose metabolism |
| AKT3 | Brain, testis | Brain development, neuronal function |
AKT2 is a critical mediator of insulin's metabolic effects:
Multiple AKT inhibitors are in clinical development:
| Model | Phenotype | Key Findings |
|---|---|---|
| Akt2 knockout mice | Growth retardation, diabetes | Essential for insulin signaling |
| Knock-in mutants | Variable | Hyperactive AKT2 causes tumors |
| Tissue-specific knockout | Metabolic defects | Brain-specific vs muscle-specific |
The study of Akt2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Bellacosa A, et al. AKT: a nodal kinase in cell signaling. Nat Rev Cancer. 2010;10(10):681-696. PMID:20852691 ↩︎
Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell. 2007;129(7):1261-1274. PMID:17604717 ↩︎
Hers I, et al. AKT signalling in health and disease. Cell Signal. 2021;79:109886. PMID:33217472 ↩︎